09/24/2026
Despite a tough global climate, Switzerland’s life sciences sector is not just resilient—it’s accelerating.
With a 38% surge in private investment and over 50 major EMEA drug launches on the horizon, Switzerland is firmly cementing itself as the strategic command centre for biopharma commercialisation. But what does this mean for the local talent gridlock?
Dan Bennett unpacks our proprietary hiring data to show you exactly where the competition for proven leadership is fiercest. Get the insights: https://ow.ly/Fi5a50ZHsF4